We are live on ! Find out more
GT

Glenmede Trust Portfolio holdings

AUM $20.4B
This Fund
S&P 500
This Quarter Est. Return
+8.99%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$21.9B
AUM Growth
+$21.9B
Cap. Flow
-$417M
Cap. Flow %
-1.9%
Top 10 Hldgs %
13.08%
Holding
3,337
New
135
Increased
1,103
Reduced
1,007
Closed
163

Top Buys

Rank Stock Value
1
BMY icon
Bristol-Myers Squibb
BMY
+$89.3M
2
KEYS icon
Keysight
KEYS
+$86M
3
NKE icon
Nike
NKE
+$78.3M
4
APH icon
Amphenol
APH
+$76.5M
5
CMCSA icon
Comcast
CMCSA
+$72.3M

Top Sells

Rank Stock Value
1
CE icon
Celanese
CE
+$108M
2
MNST icon
Monster Beverage
MNST
+$97.8M
3
SBUX icon
Starbucks
SBUX
+$79.7M
4
TXN icon
Texas Instruments
TXN
+$67.3M
5
CNC icon
Centene
CNC
+$64.3M

Sector Composition

Rank Sector Weight
1 Technology 18.83%
2 Financials 13.42%
3 Healthcare 13.25%
4 Industrials 9.77%
5 Consumer Discretionary 7.14%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
MTEM
1001
DELISTED
Molecular Templates, Inc.
MTEM
$223K ﹤0.01%
1,067
– –
CENT icon
1002
Central Garden & Pet Co
CENT
$2.78B
$221K ﹤0.01%
8,914
+993
+13% +$23.6K
XYL icon
1003
Xylem
XYL
$29.7B
$221K ﹤0.01%
2,818
+226
+9% +$17.6K
GWRE icon
1004
Guidewire Software
GWRE
$13.3B
$219K ﹤0.01%
2,000
– –
STBA icon
1005
S&T Bancorp
STBA
$1.92B
$219K ﹤0.01%
5,441
+103
+2% +$3.9K
BAC.PRL icon
1006
Bank of America Series L
BAC.PRL
$3.98B
$217K ﹤0.01%
150
– –
MAS icon
1007
Masco
MAS
$16.5B
$217K ﹤0.01%
4,548
-15,982
-78% -$727K
ALG icon
1008
Alamo Group
ALG
$2B
$216K ﹤0.01%
1,721
+268
+18% +$31.3K
HAE icon
1009
Haemonetics
HAE
$3.75B
$216K ﹤0.01%
1,881
+97
+5% +$11.7K
PRTS icon
1010
CarParts.com
PRTS
$42.4M
$216K ﹤0.01%
9,834
-973
-9% -$18.9K
FIX icon
1011
Comfort Systems
FIX
$57.2B
$214K ﹤0.01%
4,299
+720
+20% +$35K
RLI icon
1012
RLI Corp
RLI
$5.97B
$214K ﹤0.01%
4,760
-8
-0.2% -$376
SBH icon
1013
Sally Beauty Holdings
SBH
$1.48B
$214K ﹤0.01%
11,775
– –
IYF icon
1014
iShares US Financials ETF
IYF
$4.74B
$211K ﹤0.01%
3,072
– –
TAK icon
1015
Takeda Pharmaceutical
TAK
$56B
$211K ﹤0.01%
10,750
+480
+5% +$9.18K
AZPN
1016
DELISTED
ASPEN TECHNOLOGY INC
AZPN
$211K ﹤0.01%
+1,749
New +$211K
UHT
1017
Universal Health Realty Income Trust
UHT
$627M
$210K ﹤0.01%
1,791
+37
+2% +$4.21K
FMS icon
1018
Fresenius Medical Care
FMS
$13.3B
$209K ﹤0.01%
5,709
-3,699
-39% -$131K
EIS icon
1019
iShares MSCI Israel ETF
EIS
$885M
$208K ﹤0.01%
3,631
– –
ASND icon
1020
Ascendis Pharma A/S
ASND
$16.7B
$206K ﹤0.01%
+1,485
New +$165K
OZK icon
1021
Bank OZK
OZK
$5.62B
$206K ﹤0.01%
6,796
– –
ENV
1022
DELISTED
ENVESTNET, INC.
ENV
$206K ﹤0.01%
2,968
– –
DB icon
1023
Deutsche Bank
DB
$67.6B
$204K ﹤0.01%
26,303
+23,668
+898% +$178K
BG icon
1024
Bunge Global
BG
$22.8B
$203K ﹤0.01%
3,548
+2,308
+186% +$128K
VRSK icon
1025
Verisk Analytics
VRSK
$27.8B
$202K ﹤0.01%
1,358
+57
+4% +$8.45K
39 40
41
42 43

Similar funds

SLAM
Swiss Life Asset Management Zurich $20.4B AUM 28.71% 1-Year Est. Return
EWA
EP Wealth Advisors Torrance, California $20.3B AUM
MIC
Mubadala Investment Company Abu Dhabi, United Arab Emirates $20.5B AUM 19.39% 1-Year Est. Return
P
&Partners Nashville, Tennessee $20.2B AUM 19.79% 1-Year Est. Return
CI Investments Inc
CI Investments Inc Toronto, Ontario, Canada $20.6B AUM 29.22% 1-Year Est. Return
OSAM
O'Shaughnessy Asset Management Stamford, Connecticut $20.1B AUM 30.42% 1-Year Est. Return
CB
Commerce Bank Kansas City, Missouri $20.7B AUM 23.76% 1-Year Est. Return
EIM
Elliott Investment Management West Palm Beach, Florida $20.1B AUM 60.76% 1-Year Est. Return

Glenmede Trust's Q4 2019 Portfolio in Review

As of Q4 2019, Glenmede Trust held 3,337 positions worth $21.9B, up 100,205% from $21.9M the previous quarter. Its ten largest holdings account for 13% of the portfolio.

Glenmede Trust's Q4 2019 filing shows 135 new, 1,103 increased, 1,007 reduced and 163 closed positions. Its largest new stake was Callon Petroleum Company: 285,674 shares worth $13.8M. The largest sale was Celanese, an estimated $108M.

By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 17% a quarter earlier, followed by Financials and Healthcare.

  • Glenmede Trust's largest Q4 2019 buy was Callon Petroleum Company: 285,674 shares worth $13.8M.
  • Glenmede Trust added most to Bristol-Myers Squibb in Q4 2019, an estimated $89.3M increase.
  • Glenmede Trust's biggest Q4 2019 reduction was Celanese, cutting an estimated $108M.
  • Glenmede Trust fully exited Celgene Corp in Q4 2019, selling an estimated $122K.
  • Glenmede Trust's ten largest holdings make up 13% of its $21.9B portfolio in Q4 2019.
  • Glenmede Trust opened 135 new positions and closed 163 in Q4 2019.
  • Glenmede Trust's portfolio value rose 100,205% quarter-over-quarter to $21.9B.

Based on Glenmede Trust's 13F filing for Q4 2019, filed 12 Feb 2020.